申请人:MacDonald James E.
公开号:US20110117055A1
公开(公告)日:2011-05-19
Provided herein are hepatitis C virus entry inhibitor oxoacetamide compounds, pharmaceutical compositions thereof, and methods for their use in treatment or prevention of hepatitis C virus infection in a subject in need thereof.
本文提供了丙型肝炎病毒进入抑制剂羟基乙酰胺化合物,其药物组合物,以及在需要的受试者中用于治疗或预防丙型肝炎病毒感染的方法。